https://www.selleckchem.com/pr....oducts/epacadostat-i
Percutaneous left atrial appendage occlusion (LAAO) devices have emerged as alternatives to anticoagulation for embolic stroke prevention in patients with non-valvular atrial fibrillation (NVAF). The left atrial appendage is known to produce vasoactive neuroendocrine hormones involved in cardiovascular homeostasis. The hemodynamic impact of LAA occlusion on cardiac function remains poorly characterized. This is a single-center, retrospective study of sixty-seven consecutive patients who received LAAO utilizing the WATCHMA
Like
Comment
Share
